- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT03740633
Functional Training for the Prevention of Deep Venous Thrombosis
November 10, 2018 updated by: Lei Li
The Effects of Post-operative Functional Training on the Prevention of Deep Venous Thrombosis in the Patients of Gynecological Malignancies: A Phase 3 Randomized Control Study
This study aims to analyze the post-operative functional training on the prevention of deep venous thrombosis (DVT) in the patients who have accepted major surgeries for the gynecological malignancies.
The functional training consists of: (1) active and passive ankle pump motions including flexion and extension, circumduction; (2) abdominal breathing training.
The primary end is the incidence of DVT happened 30 days from surgery.
The secondary ends include the patients satisfaction about functional training.
Study Overview
Status
Unknown
Study Type
Interventional
Enrollment (Anticipated)
398
Phase
- Phase 3
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
Beijing
-
Beijing, Beijing, China, 100730
- Recruiting
- Lei Li
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Genders Eligible for Study
Female
Description
Inclusion Criteria:
- Having received major surgeries for gynecologic malignancies
- Good performance status
- Aged 18 years or older
- Signed an approved informed consents
- No injuries to the skin, musculoskeletal system
- No venous thromboembolic disease before surgeries
Exclusion Criteria:
- Not meeting all of the inclusion criteria
- Delayed extubation
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: Prevention
- Allocation: Randomized
- Interventional Model: Parallel Assignment
- Masking: Single
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
|---|---|
|
Experimental: Study group
Patients in the study group accept functional training and regular care.
|
Passive ankle pump motions include flexion and extension, circumduction, which will be conducted by caregiver on the day of surgery.
Active ankle pump motions include flexion and extension, circumduction, which will be conducted by patient on the 1-3 day after the surgery.
On the same time, the patient is given abdominal breathing training.
Regular post-operative care consists of compression stockings, anticoagulant and instructions of early mobilization
|
|
Active Comparator: Control group
Patients in the control group only accept regular care.
|
Regular post-operative care consists of compression stockings, anticoagulant and instructions of early mobilization
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
deep venous thrombosis
Time Frame: One years
|
incidence of deep venous thrombosis
|
One years
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
adverse events
Time Frame: One year
|
adverse events related to the functional training
|
One year
|
|
patient satisfaction
Time Frame: One year
|
patient satisfaction surveyed by customed questionnaire
|
One year
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
November 10, 2018
Primary Completion (Anticipated)
November 10, 2019
Study Completion (Anticipated)
November 10, 2019
Study Registration Dates
First Submitted
November 10, 2018
First Submitted That Met QC Criteria
November 10, 2018
First Posted (Actual)
November 14, 2018
Study Record Updates
Last Update Posted (Actual)
November 14, 2018
Last Update Submitted That Met QC Criteria
November 10, 2018
Last Verified
November 1, 2018
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- GO-FUN
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Deep Venous Thrombosis
-
Hospital de Clinicas de Porto AlegreCompletedDeep Venous Thromboses | Deep Venous Thrombosis of Left Leg | Deep Venous Thrombosis of Right Leg | Deep Venous Thrombosis Proximal
-
Intermountain Health Care, Inc.TerminatedDeep Vein Thrombosis | Venous Thromboembolism | Deep Venous Thrombosis | Thrombus | Upper Extremity Deep Venous ThrombosisUnited States
-
Tong ZhuNot yet recruitingDeep Vein Thrombosis | Deep Venous Insufficiency
-
Maastricht University Medical CenterTerminatedRandomized Clinical Trial | Deep-Venous Thrombosis | Deep Venous StentingNetherlands
-
Memorial Sloan Kettering Cancer CenterRecruitingVenous Thromboembolism | Deep Venous ThrombosisUnited States, Australia
-
Al-Nahrain UniversityNot yet recruitingDVT - Deep Vein Thrombosis | VTE (Venous Thromboembolism)Iraq
-
Imperial College LondonWithdrawnDeep Vein Thrombosis | Deep Venous Thrombosis of LegUnited Kingdom
-
University of Massachusetts, AmherstCompletedDeep Venous Thrombosis of Deep Femoral VeinUnited States
-
Milton S. Hershey Medical CenterEnrolling by invitation
-
Ottawa Hospital Research InstituteUniversity of Alberta; Hamilton Health Sciences Corporation; Queen Elizabeth...CompletedThromboprophylaxis With Rivaroxaban In Patients With Malignancy and Central Venous Lines (TRIM-Line)Cancer | Central Venous Catheter Thrombosis | Upper Extremity Deep Vein ThrombosisCanada
Clinical Trials on passive ankle pump motions on the day of surgery
-
Kirill GromovRigshospitalet, Denmark; Vejle Hospital; Holsterbro Sygehus, DKCompleted
-
Helsinki University Central HospitalTurku University Hospital; Oulu University HospitalCompletedCervical RadiculopathyFinland
-
Wesley Justino MagnaboscoCompletedProstatic NeoplasmsBrazil
-
The Royal Bournemouth HospitalCompletedArthroplasty, Replacement, Hip | Hip Replacement, TotalUnited Kingdom
-
Beni-Suef UniversityCompletedPostoperative Cognitive DysfunctionEgypt
-
Centre Hospitalier Universitaire DijonCompleted
-
Zhongnan HospitalCompleted
-
Assiut UniversityUnknown
-
Jinan Central HospitalUnknownIn Vitro Fertilization | Frozen Embryo TransferChina
-
Population Health Research InstituteCharles University, Czech Republic; Centre hospitalier de l'Université de Montréal... and other collaboratorsCompletedthe Efficacy and Safety of Off-pump CABGCanada, China, Colombia, India, Chile, Argentina, Brazil, Czech Republic, France, Italy, Poland, Turkey, United Kingdom